BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32750501)

  • 1. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.
    Cibula D; Kocian R; Plaikner A; Jarkovsky J; Klat J; Zapardiel I; Pilka R; Torne A; Sehnal B; Ostojich M; Petiz A; Sanchez OA; Presl J; Buda A; Raspagliesi F; Kascak P; van Lonkhuijzen L; Barahona M; Minar L; Blecharz P; Pakiz M; Wydra D; Snyman LC; Zalewski K; Zorrero C; Havelka P; Redecha M; Vinnytska A; Vergote I; Tingulstad S; Michal M; Kipp B; Slama J; Marnitz S; Bajsova S; Hernandez A; Fischerova D; Nemejcova K; Kohler C
    Eur J Cancer; 2020 Sep; 137():69-80. PubMed ID: 32750501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
    Cibula D; Dusek J; Jarkovsky J; Dundr P; Querleu D; van der Zee A; Kucukmetin A; Kocian R
    Int J Gynecol Cancer; 2019 Jan; 29(1):212-215. PubMed ID: 30640706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer.
    Rychlik A; Angeles MA; Migliorelli F; Croce S; Mery E; Martinez A; Ferron G; Guyon F; Querleu D
    Int J Gynecol Cancer; 2020 Mar; 30(3):358-363. PubMed ID: 31911532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
    Diaz JP; Gemignani ML; Pandit-Taskar N; Park KJ; Murray MP; Chi DS; Sonoda Y; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2011 Mar; 120(3):347-52. PubMed ID: 21216450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging.
    Balaya V; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngô C; Le Frère-Belda MA; Mathevet P; Lécuru F
    Gynecol Oncol; 2020 Sep; 158(3):576-583. PubMed ID: 32595022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node in cervical cancer: time to move forward.
    Balaya V; Guani B; Pache B; Durand YG; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F
    Chin Clin Oncol; 2021 Apr; 10(2):18. PubMed ID: 33951917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbon nanoparticle tracing of sentinel lymph nodes in diagnosis and treatment of cervical cancer and clinical value of lymph node ultrastaging detection].
    Lin X; He J; Lu J; Huang C; Liu N
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1896-1901. PubMed ID: 36651260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Wess B; Kohler C; Plaikner A; El-Safadi S; Schwandner T; Meinhold-Heerlein I; Favero G
    Int J Gynecol Cancer; 2024 May; 34(5):675-680. PubMed ID: 38485222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
    Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
    J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sentinel lymph node biopsy in early-stage cervical cancer: current state of art].
    Balaya V; Guani B; Bonsang-Kitzis H; Deloménie M; Ngô C; Montero Macias R; Koual M; Nguyen-Xuan HT; Bats AS; Mathevet P; Lécuru F
    Bull Cancer; 2020 Jun; 107(6):696-706. PubMed ID: 31627905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer.
    Dostalek L; Slama J; Fisherova D; Kocian R; Germanova A; Fruhauf F; Dusek L; Dundr P; Nemejcova K; Jarkovsky J; Cibula D
    Int J Gynecol Cancer; 2020 Jun; 30(6):744-748. PubMed ID: 32276933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Santoro A; Angelico G; Inzani F; Arciuolo D; Spadola S; Valente M; D'Alessandris N; Piermattei A; Fiorentino V; CIanfrini F; Bizzarri N; Pedone Anchora L; Fagotti A; Scambia G; Zannoni GF
    Int J Gynecol Cancer; 2020 Dec; 30(12):1871-1877. PubMed ID: 33127865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Lührs O; Ekdahl L; Geppert B; Lönnerfors C; Persson J
    Gynecol Oncol; 2021 Nov; 163(2):289-293. PubMed ID: 34509298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential risks in sentinel lymph node biopsy for cervical cancer: a single-institution pilot study.
    Tu H; Wan T; Zhang X; Gu H; Feng Y; Huang H; Liu J
    World J Surg Oncol; 2020 Jun; 18(1):133. PubMed ID: 32552905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
    Tu H; Huang H; Xian B; Li J; Wang P; Zhao W; Chen X; Xie X; Wang C; Kong B; Xiao J; Zhang P; Liu J;
    Int J Gynecol Cancer; 2020 Nov; 30(11):1829-1833. PubMed ID: 32973117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.
    Cusimano MC; Walker R; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Murphy J; Rosen B; Covens A; Clarke B; Shaw P; Rouzbahman M; Mohan R; Ferguson SE
    J Obstet Gynaecol Can; 2017 Aug; 39(8):659-667. PubMed ID: 28729099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.